TCMD Tactile Systems Technology, Inc.
USHealthcareAs of 2026-07-10 16:00
Why TCMD matters now
Tactile Systems Technology, Inc. (TCMD) is a US stock in Healthcare. The latest InvestLog snapshot shows $29.83 with -2.77% on the session and $672.9M in market capitalization; recent performance reads 1-month +9.73% and YTD -8.21%.
The latest financial table shown here is Q1 2026, with revenue of $75.3M, net income of $-1.8M, and EPS of $-0.08. Investors can compare that operating picture with valuation signals such as P/E 28.67 and FCF yield 6.5%.
The latest indexable market news headline is "Tactile Systems Technology (TCMD) Moves 8.1% Higher: Will This Strength Last?" from Zacks Investment Research.
Additional event context on this page matters because analyst consensus is Buy with a median target of $40.00; recent insider activity includes Birkemeyer Elaine M. filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
28.67
PEG
2.29
P/B
2.76
P/S
1.75
EV/EBITDA
13.02
DCF Value
$66.58
FCF Yield
6.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
75.7%
Operating Margin
9.4%
Net Margin
5.9%
ROE
9.7%
ROA
7.5%
ROIC
7.9%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $75.3M | $-1.8M | $-0.08 |
| Q4 2025 | $103.6M | $10.6M | $0.46 |
| FY 2025 | $329.5M | $19.1M | $0.82 |
| Q3 2025 | $85.8M | $8.2M | $0.36 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$39.25
Target (Median)
$40.00
Target Range
$35.00 - $42.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
0.83
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.